1. Home
  2. VNCE vs AKTX Comparison

VNCE vs AKTX Comparison

Compare VNCE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$3.46

Market Cap

32.8M

ML Signal

HOLD

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

HOLD

Current Price

$0.24

Market Cap

14.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
AKTX
Founded
2002
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.8M
14.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
VNCE
AKTX
Price
$3.46
$0.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.88
$3.30
AVG Volume (30 Days)
196.3K
1.6M
Earning Date
02-01-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$296,250,000.00
N/A
Revenue This Year
$1.48
N/A
Revenue Next Year
$4.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.58
N/A
52 Week Low
$1.02
$0.22
52 Week High
$6.89
$1.73

Technical Indicators

Market Signals
Indicator
VNCE
AKTX
Relative Strength Index (RSI) 66.80 28.78
Support Level $3.30 $0.22
Resistance Level $3.75 $0.47
Average True Range (ATR) 0.26 0.08
MACD 0.07 -0.00
Stochastic Oscillator 80.00 6.94

Price Performance

Historical Comparison
VNCE
AKTX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: